These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27931579)

  • 41. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
    Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U
    Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical efficacy and prognostic risk factors of salvage liver transplantation, rehepatectomy, and local ablation in the treatment of postoperative recurrence of hepatocellular carcinoma].
    Lin P; You YK; Liu JY; Yang F; Cai QC; Jiang Y; Shen JJ
    Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):155-160. PubMed ID: 37137830
    [No Abstract]   [Full Text] [Related]  

  • 43. Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.
    Menahem B; Lubrano J; Duvoux C; Mulliri A; Alves A; Costentin C; Mallat A; Launoy G; Laurent A
    Liver Transpl; 2017 Jun; 23(6):836-844. PubMed ID: 28295992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis B virus.
    Hu Z; Zhou J; Li Z; Xiang J; Qian Z; Wu J; Zhang M; Zheng S
    Surgery; 2015 Feb; 157(2):239-48. PubMed ID: 25616940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation.
    Lee HS; Choi GH; Joo DJ; Kim MS; Choi JS; Kim SI
    Ann Surg Oncol; 2014 Aug; 21(8):2717-24. PubMed ID: 24916744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laparoscopic hepatectomy produces better outcomes for hepatolithiasis than open hepatectomy: An updated systematic review and meta-analysis.
    Liu X; Min X; Ma Z; He X; Du Z
    Int J Surg; 2018 Mar; 51():151-163. PubMed ID: 29367038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials.
    Si T; Chen Y; Ma D; Gong X; Yang K; Guan R; Peng C
    Scand J Gastroenterol; 2016 Dec; 51(12):1512-1519. PubMed ID: 27598831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation.
    Liu B; Teng F; Fu H; Guo WY; Shi XM; Ni ZJ; Gao XG; Ma J; Fu ZR; Ding GS
    BMC Gastroenterol; 2015 Oct; 15():138. PubMed ID: 26472203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation the efficacy and safety of simultaneous splenectomy in liver transplantation patients: A meta-analysis.
    He C; Liu X; Peng W; Li C; Wen TF
    Medicine (Baltimore); 2018 Mar; 97(10):e0087. PubMed ID: 29517676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical management of hepatocellular carcinoma: is the jury still out?
    Morris-Stiff G; Gomez D; de Liguori Carino N; Prasad KR
    Surg Oncol; 2009 Dec; 18(4):298-321. PubMed ID: 19062271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma.
    Abe T; Tashiro H; Teraoka Y; Hattori M; Tanimine N; Kuroda S; Tahara H; Ohira M; Tanaka Y; Kobayashi T; Ide K; Ishiyama K; Ohdan H
    Dig Surg; 2016; 33(1):8-14. PubMed ID: 26551258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation.
    Yamashita Y; Yoshida Y; Kurihara T; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Uchiyama H; Shirabe K; Maehara Y
    Liver Transpl; 2015 Jul; 21(7):961-8. PubMed ID: 25772591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
    Fuks D; Dokmak S; Paradis V; Diouf M; Durand F; Belghiti J
    Hepatology; 2012 Jan; 55(1):132-40. PubMed ID: 21932387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma.
    Hwang S; Lee SG; Moon DB; Ahn CS; Kim KH; Lee YJ; Ha TY; Song GW
    Liver Transpl; 2007 May; 13(5):741-6. PubMed ID: 17457860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
    Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
    Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
    Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Right lobe split liver transplantation versus whole liver transplantation in adult recipients: A systematic review and meta-analysis.
    Wan P; Li Q; Zhang J; Xia Q
    Liver Transpl; 2015 Jul; 21(7):928-43. PubMed ID: 25832308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.